- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 1/14 - ExtractionSéparationPurification
Détention brevets de la classe C07K 1/14
Brevets de cette classe: 1683
Historique des publications depuis 10 ans
|
120
|
114
|
119
|
138
|
146
|
116
|
110
|
124
|
95
|
69
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Genentech, Inc. | 4132 |
22 |
| Industry-university Cooperation Foundation Hanyang University Erica Campus | 651 |
22 |
| Amgen Inc. | 4467 |
20 |
| Kaneka Corporation | 4775 |
16 |
| Bio-Rad Laboratories, Inc. | 1608 |
16 |
| Chugai Seiyaku Kabushiki Kaisha | 1426 |
15 |
| Takeda Pharmaceutical Company Limited | 2700 |
14 |
| Hoffmann-La Roche Inc. | 3841 |
13 |
| Agency for Science, Technology and Research | 3765 |
12 |
| Boehringer Ingelheim International GmbH | 4479 |
10 |
| Burcon NutraScience (MB) Corp. | 129 |
10 |
| Bristol-myers Squibb Company | 4757 |
9 |
| The Regents of the University of California | 20902 |
9 |
| Novozymes A/S | 3394 |
9 |
| Spiber Inc. | 237 |
9 |
| Merck Patent GmbH | 5747 |
8 |
| Hybio Pharmaceutical Co., Ltd. | 121 |
8 |
| Regeneron Pharmaceuticals, Inc. | 4810 |
8 |
| BASF SE | 21320 |
7 |
| Bayer HealthCare LLC | 1298 |
7 |
| Autres propriétaires | 1439 |